oncology management

Feature

Multidisciplinary Management of Multiple Myeloma in Older Adults

08/17/2017

Nader Tavakoli, MD, CMD, FAAFP

Sidrah Khan, MD

Shelby Knowles, MD

Richard Stefanacci, DO, MGH, MBA, AGSF, CMD

Abstract: Multiple myeloma (MM) is a progressive and fatal disease, primarily affecting men aged 66 years or older. Because MM is primarily a disease of the elderly, it is incumbent on geriatricians and primary care...

...

08/17/2017

Journal of Clinical Pathways

Research in Review

ED Visits Prevented Through Improved Cancer Symptom Management and Outpatient Care

06/15/2017

JCP Editors

Better symptom management and readily available outpatient care for patients with cancer can reduce emergency department (ED) visits that do not require admission by as much as 53%, according to a recent...

Better...

06/15/2017

Journal of Clinical Pathways

Guideline-Recommended Therapy Underused in Rare Form of Bladder Cancer

05/16/2017

JCP Editors

Recommended primary treatment for non-muscle invasive micropapillary urothelial carcinoma (MPBC) is often foregone in community cancer centers and academic centers, according to a study presented at the American...

...

05/16/2017

Journal of Clinical Pathways

Research in Review

A Road Map for Using Biomarkers in Clinical Practice

12/16/2016

JCP Editors

New consensus guidelines provide a "road map" for the appropriate implementation of imaging biomarkers in clinical practice. ----- Related Content Biomarkers Predict Cetuximab Performance in Metastatic Colorectal...

New...

12/16/2016

Journal of Clinical Pathways

Research in Review

Feedback System Improves Physician Adherence to Oncology Clinical Pathways

11/15/2016

JCP Editors

While clinical pathways have emerged as a way of reducing care variability and standardizing best practice, some institutions that implement these tools still face difficulties with physician buy-in and adherence to...

While...

11/15/2016

Journal of Clinical Pathways

Research in Review

TKI Shows Promise in Sarcoma Study

11/10/2016

JCP Editors

Tivozanib was well-tolerated and showed promising antitumor activity in patients with soft tissue sarcoma overexpressing vascular endothelial growth factors (VEGF), supporting efforts for further research, according...

...

11/10/2016

Journal of Clinical Pathways

Quiz

A Flawed Biomarker for Bladder Cancer?

11/03/2016

JCP Editors

While previously reported as a promising biomarker for bladder cancer, a recent study published in Cancer found that which of the following was not a reliable predictor of cancer progression or treatment...

...

11/03/2016

Journal of Clinical Pathways

Research in Review

Bloodstream Infections Increase Costs, Length of Stay for Pediatric Cancer and Transplant Patients

09/06/2016

JCP Editors

Pediatric oncology and stem cell transplant patients with ambulatory bloodstream infections have higher health care costs and unplanned extended hospital admissions, claims a recent study. ----- Related...

...

09/06/2016

Journal of Clinical Pathways

Research in Review

Formula for Optimal Radiosurgery Dose Developed to Guide Brain Metastasis Treatment

06/15/2016

JCP Editors

Researchers from the department of radiation oncology at the VU University Medical Center in Amsterdam, the Netherlands, have proposed a novel formula for the optimization of radiosurgery dose for any given lesion...

...

06/15/2016

Journal of Clinical Pathways

Research in Review

Adherence to Oral Antineoplastic Therapies a Problem for Patients and Providers

03/08/2016

JCP Editors

A study has shown that a high number of patients struggle to adhere to oral antineoplastic therapies as prescribed by their provider. Antineoplastic agents are oral drugs that help to halt the process of cell...

A...

03/08/2016

Journal of Clinical Pathways